Your browser doesn't support javascript.
loading
Medicinal chemistry advances in targeting class I histone deacetylases.
Abdallah, Diaaeldin I; de Araujo, Elvin D; Patel, Naman H; Hasan, Lina S; Moriggl, Richard; Krämer, Oliver H; Gunning, Patrick T.
  • Abdallah DI; Department of Chemical & Physical Sciences, University of Toronto Mississauga, Mississauga, Ontario L5L 1C6, Canada.
  • de Araujo ED; Department of Chemistry, University of Toronto, Toronto, Ontario M5S 2E8, Canada.
  • Patel NH; Department of Chemical & Physical Sciences, University of Toronto Mississauga, Mississauga, Ontario L5L 1C6, Canada.
  • Hasan LS; Department of Chemical & Physical Sciences, University of Toronto Mississauga, Mississauga, Ontario L5L 1C6, Canada.
  • Moriggl R; Department of Chemical & Physical Sciences, University of Toronto Mississauga, Mississauga, Ontario L5L 1C6, Canada.
  • Krämer OH; Institute of Animal Breeding and Genetics, University of Veterinary Medicine, 1210 Vienna, Austria.
  • Gunning PT; Department of Toxicology, University of Mainz Medical Center, 55131 Mainz, Germany.
Explor Target Antitumor Ther ; 4(4): 757-779, 2023.
Article en En | MEDLINE | ID: mdl-37711592